Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated:  12/21/2017
Primary Children's Hospital
mi
from
Salt Lake City, UT
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated: 12/21/2017
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated:  12/21/2017
Sick Children's Hospital
mi
from
Toronto,
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated: 12/21/2017
Sick Children's Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Comparison of Culture Media for in Vitro Embryo Development
Prospective Observational Study Utilizing Next Generation Continuous Single Culture Media (CSCM2) for Comparative in Vitro Embryo Development and Outcome Data
Status: Enrolling
Updated:  12/22/2017
Ovation Fertility - Austin
mi
from
Austin, TX
Comparison of Culture Media for in Vitro Embryo Development
Prospective Observational Study Utilizing Next Generation Continuous Single Culture Media (CSCM2) for Comparative in Vitro Embryo Development and Outcome Data
Status: Enrolling
Updated: 12/22/2017
Ovation Fertility - Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator
Prospective Observational and Validation Study Using Time-lapse Morphometry MIRI Imaging Incubator (TiMMI Study)
Status: Enrolling
Updated:  12/22/2017
Ovation Fertility
mi
from
Austin, TX
Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator
Prospective Observational and Validation Study Using Time-lapse Morphometry MIRI Imaging Incubator (TiMMI Study)
Status: Enrolling
Updated: 12/22/2017
Ovation Fertility
mi
from
Austin, TX
Click here to add this to my saved trials
Impact of Hot Flashes on Sleep and Mood Disturbance
Impact of Experimentally Induced Hot Flashes on Sleep and Mood Disturbance
Status: Enrolling
Updated:  12/26/2017
Massachusetts General Hospital
mi
from
Boston, MA
Impact of Hot Flashes on Sleep and Mood Disturbance
Impact of Experimentally Induced Hot Flashes on Sleep and Mood Disturbance
Status: Enrolling
Updated: 12/26/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Northwestern University
mi
from
Chicago, IL
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Wayne State University
mi
from
Detroit, MI
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Columbia University
mi
from
New York, NY
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Case Western University
mi
from
Cleveland, OH
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Case Western University
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Dexel University
mi
from
Philadelphia, PA
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Dexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Pittsburgh-Magee Womens Hospital
mi
from
Pittsburgh, PA
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Pittsburgh-Magee Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Brown University
mi
from
Providence, RI
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Texas - Southwest
mi
from
Dallas, TX
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Texas - Southwest
mi
from
Dallas, TX
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
The University of Texas, Houston
mi
from
Houston, TX
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Utah Medical Center
mi
from
Salt Lake City, UT
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Utah Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
A Phase II Trial of Bevacizumab (rhuMAB VEGF) (NSC #704865) in the Treatment of Persistent and Recurrent Squamous Cell Carcinoma of the Cervix (Group A)
Status: Enrolling
Updated:  12/27/2017
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
A Phase II Trial of Bevacizumab (rhuMAB VEGF) (NSC #704865) in the Treatment of Persistent and Recurrent Squamous Cell Carcinoma of the Cervix (Group A)
Status: Enrolling
Updated: 12/27/2017
Gynecologic Oncology Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Status: Enrolling
Updated:  12/30/2017
William Beaumont Hospital
mi
from
Royal Oak, MI
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Status: Enrolling
Updated: 12/30/2017
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Recombinant Human Prolactin for Lactation Induction
Recombinant Human Prolactin for Lactation Induction in Mothers of Premature Infants
Status: Enrolling
Updated:  12/31/2017
Massachusetts General Hospital
mi
from
Boston, MA
Recombinant Human Prolactin for Lactation Induction
Recombinant Human Prolactin for Lactation Induction in Mothers of Premature Infants
Status: Enrolling
Updated: 12/31/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
Phase I Investigation of the Feasibility of Combining 5-azacytidine With Highdose Cytarabine (HiDAC) and Mitoxantrone Chemotherapy in a Sequential Manner for Remission Induction in High-risk Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  1/2/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
Phase I Investigation of the Feasibility of Combining 5-azacytidine With Highdose Cytarabine (HiDAC) and Mitoxantrone Chemotherapy in a Sequential Manner for Remission Induction in High-risk Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 1/2/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated:  1/3/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated: 1/3/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated:  1/3/2018
University of Oklahoma Children's Hospital
mi
from
Oklahoma City, OK
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated: 1/3/2018
University of Oklahoma Children's Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) - Phase 1 Clinical Trial
Status: Enrolling
Updated:  1/3/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) - Phase 1 Clinical Trial
Status: Enrolling
Updated: 1/3/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated:  1/3/2018
Denver Health
mi
from
Denver, CO
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated: 1/3/2018
Denver Health
mi
from
Denver, CO
Click here to add this to my saved trials
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated:  1/3/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated: 1/3/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Birmingham, AL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Cullman, AL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Cullman, AL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Mobile, AL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Chandler, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Goodyear, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Tucson, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Little Rock, AR
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Artesia, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Artesia, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Carmichael, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Carmichael, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Chino, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Encinitas, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
San Diego, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Colorado Springs, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Denver, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Lakewood, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Lonetree, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Lonetree, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Groton, CT
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Groton, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
New London, CT
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
New London, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Southington, CT
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Southington, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Clearwater, FL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials